Sharon N. Edmiston

5.5k total citations · 1 hit paper
35 papers, 4.0k citations indexed

About

Sharon N. Edmiston is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Sharon N. Edmiston has authored 35 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 18 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Sharon N. Edmiston's work include Cutaneous Melanoma Detection and Management (9 papers), Epigenetics and DNA Methylation (8 papers) and Cancer-related Molecular Pathways (7 papers). Sharon N. Edmiston is often cited by papers focused on Cutaneous Melanoma Detection and Management (9 papers), Epigenetics and DNA Methylation (8 papers) and Cancer-related Molecular Pathways (7 papers). Sharon N. Edmiston collaborates with scholars based in United States, Australia and India. Sharon N. Edmiston's co-authors include Kathleen Conway, Robert C. Millikan, Chiu Kit Tse, Joseph Geradts, Chad Livasy, Melissa A. Troester, Lisa A. Carey, Lynn G. Dressler, David P. Cowan and Maggie C.U. Cheang and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Sharon N. Edmiston

33 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

2006 3.0k citations Lisa A. Carey, Charles M. Perou et al. JAMA profile →

Peers

Countries citing papers authored by Sharon N. Edmiston

Since Specialization

Citations

This map shows the geographic impact of Sharon N. Edmiston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon N. Edmiston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon N. Edmiston more than expected).

Fields of papers citing papers by Sharon N. Edmiston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon N. Edmiston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon N. Edmiston. The network helps show where Sharon N. Edmiston may publish in the future.

Co-authorship network of co-authors of Sharon N. Edmiston

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon N. Edmiston. A scholar is included among the top collaborators of Sharon N. Edmiston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon N. Edmiston. Sharon N. Edmiston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Region of Interest Detection in Melanocytic Skin Tumor Whole Slide Images—Nevus and Melanoma 2024 ·Cancers ·Yi Cui, Yao Li, (unknown), Sharon N. Edmiston, (unknown), J. S. Marron, Nancy E. Thomas	0
2	Association of functional, inherited vitamin D–binding protein variants with melanoma-specific death 2023 ·JNCI Cancer Spectrum ·David C. Gibbs, Nancy E. Thomas, Peter A. Kanetsky, Li Luo, Klaus J. Busam, Anne Ε. Cust, Hoda Anton‐Culver, Richard P. Gallagher, Roberto Zanetti, Stefano Rosso, Lidia Sacchetto, Sharon N. Edmiston, Kathleen Conway, David W. Ollila, Colin B. Begg, Marianne Berwick, Sarah V. Ward, Irene Orlow	1
3	Pathway Alterations in Stage II/III Primary Melanoma 2023 ·JCO Precision Oncology ·(unknown), Li Luo, Arshi Arora, Venkatraman Seshan, Marc S. Ernstoff, Sharon N. Edmiston, Kathleen Conway, (unknown), Klaus J. Busam, Irene Orlow, Eva Hernando, Nancy E. Thomas, Marianne Berwick, Colin B. Begg, Ronglai Shen, (unknown)	2
4	Characterization of the CpG Island Hypermethylated Phenotype Subclass in Primary Melanomas 2021 ·Journal of Investigative Dermatology ·Kathleen Conway, Yi‐Hsuan Tsai, Sharon N. Edmiston, Joel S. Parker, Eloise Parrish, Honglin Hao, Pei Fen Kuan, Glynis Scott, Jill S. Frank, Paul B. Googe, David W. Ollila, Nancy E. Thomas	8
5	Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis 2018 ·Journal of Investigative Dermatology ·Kathleen Conway, Sharon N. Edmiston, Joel S. Parker, Pei Fen Kuan, Yi‐Hsuan Tsai, Pamela A. Groben, Daniel C. Zedek, Glynis Scott, Eloise Parrish, Honglin Hao, (unknown), Jill S. Frank, Craig C. Carson, Matthew D. Wilkerson, Xiaobei Zhao, (unknown), Stergios J. Moschos, David W. Ollila, Nancy E. Thomas	25
6	Utility of TERT Promoter Mutations for Cutaneous Primary Melanoma Diagnosis 2018 ·American Journal of Dermatopathology ·Nancy E. Thomas, Sharon N. Edmiston, Yi‐Hsuan Tsai, Joel S. Parker, Paul B. Googe, Klaus J. Busam, Glynis Scott, Daniel C. Zedek, Eloise Parrish, Honglin Hao, (unknown), (unknown), Jill S. Frank, Pei Fen Kuan, David W. Ollila, Kathleen Conway	26
7	Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study 2017 ·Breast Cancer Research and Treatment ·Kathleen Conway, Sharon N. Edmiston, Eloise Parrish, Chris Bryant, Chiu-Kit Tse, Theresa Swift‐Scanlan, Lauren E. McCullough, Pei Fen Kuan	18
8	Body Mass Index Is Associated with Gene Methylation in Estrogen Receptor–Positive Breast Tumors 2015 ·Cancer Epidemiology Biomarkers & Prevention ·Brionna Y. Hair, Melissa A. Troester, Sharon N. Edmiston, Eloise Parrish, Whitney R. Robinson, Michael C. Wu, Andrew F. Olshan, Theresa Swift‐Scanlan, Kathleen Conway	24
9	DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features 2014 ·Pigment Cell & Melanoma Research ·Nancy E. Thomas, (unknown), Sharon N. Edmiston, Xin Zhou, Pei Fen Kuan, Pamela A. Groben, Craig C. Carson, Honglin Hao, Eloise Parrish, Stergios J. Moschos, Marianne Berwick, David W. Ollila, Kathleen Conway	19
10	DNA‐methylation profiling distinguishes malignant melanomas from benign nevi 2011 ·Pigment Cell & Melanoma Research ·Kathleen Conway, Sharon N. Edmiston, Zakaria Khondker, Pamela A. Groben, Xin Zhou, Haitao Chu, Pei Fen Kuan, Honglin Hao, Craig C. Carson, Marianne Berwick, (unknown), Nancy E. Thomas	57
11	Altered-Function p53 Missense Mutations Identified in Breast Cancers Can Have Subtle Effects on Transactivation 2010 ·Molecular Cancer Research ·Jennifer Jordan, Alberto Inga, Kathleen Conway, Sharon N. Edmiston, Lisa A. Carey, Lin Wu, Michael A. Resnick	56
12	FAK overexpression and p53 mutations are highly correlated in human breast cancer 2009 ·International Journal of Cancer ·Vita Golubovskaya, Kathleen Conway‐Dorsey, Sharon N. Edmiston, Chiu‐Kit Tse, (unknown), Chad Livasy, Dominic Moore, Robert C. Millikan, William G. Cance	68
13	Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation 2007 ·Breast Cancer Research ·Kathleen Conway, Eloise Parrish, Sharon N. Edmiston, Dawn Tolbert, (unknown), Patricia G. Moorman, Beth Newman, Robert C. Millikan	2
14	Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study breakdown → 2006 ·JAMA ·Lisa A. Carey, Charles M. Perou, Chad Livasy, Lynn G. Dressler, David P. Cowan, Kathleen Conway, Gamze Karaca, Melissa A. Troester, Chiu Kit Tse, Sharon N. Edmiston, Sandra L. Deming, Joseph Geradts, Maggie C.U. Cheang, Torsten O. Nielsen, Patricia G. Moorman, H. Shelton Earp, Robert C. Millikan	2986
15	The Estrogen Receptor-Alpha A908 (k303R) Mutation Occurs at a Low Frequency in Invasive Breast Tumors: Results From a Population-Based Study 2005 ·Kathleen Conway, Sharon N. Edmiston, Joseph Geradts, Chad Livasy, Robert C. Millikan, Beth Newman, Eloise Parrish, Harsharan K. Singh, Dawn Tolbert, Chiu‐Kit Tse	15
16	IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project 2005 ·Carcinogenesis ·Rebecca J. Cleveland, Marilie D. Gammon, Sharon N. Edmiston, Susan L. Teitelbaum, Julie A. Britton, Mary Beth Terry, Sybil M. Eng, Alfred I. Neugut, Regina M. Santella, Kathleen Conway	54
17	Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. 2000 ·PubMed ·Robert C. Millikan, Emily DeVoto, Eric J. Duell, Chiu Kit Tse, David A. Savitz, Jennifer Beach, Sharon N. Edmiston, Susan T. Jackson, Beth Newman	102
18	Lack of association of rare alleles in the HRAS variable numberof tandem repeats (VNTR) region with adult glioma 2000 ·Neuro-Oncology ·Pengchin Chen, John K. Wiencke, Kathleen Conway, Sharon N. Edmiston, Rei Miike, Margaret Wrensch	3
19	Ha-ras rare alleles in breast cancer susceptibility 1995 ·Breast Cancer Research and Treatment ·Kathleen Conway, Sharon N. Edmiston, Daniel B. Fried, Barbara S. Hulka, (unknown), Edison T. Liu	6
20	A cell-based reporter assay for the identification of protein kinase C activators and inhibitors 1994 ·Molecular and Cellular Biochemistry ·Prakash Sista, Sharon N. Edmiston, (unknown), Simon P. Robinson, David J. Burns	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact